Medicare Enrolled
Dr. Nabil Gerges, DO
Pain Medicine · Clearwater, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gerges from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gerges?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gerges
Dr. Nabil Gerges is a pain medicine specialist in Clearwater, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Gerges performed 7,572 Medicare services across 2,746 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gerges received a total of $24,200 from 67 pharmaceutical and/or device companies across 1111 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gerges is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 12% volume in FL
$24,200 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Osteopathic Physician | 10298 | Clear | March 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗7,572
Medicare services
Top 12% in FL for pain medicine
2,746
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~445 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 2,914 | $93 | $645 |
| Betamethasone steroid injection | 824 | $5 | $35 |
| Evaluation of psychological test, first hour | 523 | $83 | $250 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 456 | $194 | $1,245 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 399 | $14 | $100 |
| Testing for presence of drug, read by direct observation | 286 | $12 | $89 |
| Ultrasonic guidance for needle placement | 260 | $45 | $439 |
| Injection of trigger points, 1-2 muscles | 241 | $37 | $335 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 213 | $49 | $1,062 |
| Office visit, established patient (20-29 min) | 191 | $69 | $437 |
| Injection into tendon or ligament | 182 | $57 | $356 |
| Joint injection, major joint | 106 | $50 | $369 |
| Injection of trigger points, 3 or more muscles | 99 | $41 | $386 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 97 | $107 | $1,051 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 94 | $154 | $2,574 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 87 | $62 | $528 |
| New patient office visit (45-59 min) | 87 | $124 | $1,000 |
| Injection of substance into lower spine canal using imaging guidance | 84 | $76 | $641 |
| Destruction of peripheral nerve or branch | 80 | $48 | $804 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 77 | $54 | $1,178 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 43 | $24 | $480 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 33 | $94 | $979 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 29 | $118 | $1,169 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 29 | $67 | $577 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 27 | $150 | $2,611 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 22 | $89 | $1,333 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 22 | $160 | $1,245 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 20 | $42 | $534 |
| Injection of substance into middle or upper spine canal using imaging guidance | 19 | $86 | $659 |
| X-ray of lower and sacral spine, minimum of 4 views | 15 | $37 | $299 |
| Shoulder X-ray, 2+ views | 13 | $27 | $190 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$24,200
Total received (2018-2024)
Avg $3,457/year across 7 years
Top 7% in FL for pain medicine
67
Companies
1,111
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,262 (63.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,938 (36.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,926
2023
$1,650
2022
$1,888
2021
$2,460
2020
$1,650
2019
$2,842
2018
$11,785
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Assertio Therapeutics, Inc.
$8,837
Collegium Pharmaceutical, Inc.
$1,553
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,368
PFIZER INC.
$1,069
Supernus Pharmaceuticals, Inc.
$982
Abbott Laboratories
$679
Nevro Corp.
$615
SCILEX PHARMACEUTICALS INC.
$504
Scilex Pharmaceuticals Inc.
$478
Eisai Inc.
$442
Biohaven Pharmaceuticals, Inc.
$435
Novartis Pharmaceuticals Corporation
$421
PROTEGA PHARMACEUTIALS INC
$390
ABBVIE INC.
$389
Horizon Therapeutics plc
$376
Daiichi Sankyo Inc.
$363
Electronic Waveform Lab, Inc.
$336
AbbVie Inc.
$336
Takeda Pharmaceuticals U.S.A., Inc.
$294
Amgen Inc.
$285
Stimwave Technologies Incorporated
$266
BioDelivery Sciences International, Inc.
$261
IBSA Pharma Inc.
$252
Biohaven Pharmaceutical Holding Company Ltd.
$238
Teva Pharmaceuticals USA, Inc.
$222
IDORSIA PHARMACEUTICALS US INC
$198
ASSERTIO THERAPEUTICS, Inc.
$190
Almatica Pharma LLC
$187
Egalet US Inc
$185
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$155
Allergan, Inc.
$152
Pernix Therapeutics Holdings, Inc.
$152
Azurity Pharmaceuticals, Inc.
$130
Boston Scientific Corporation
$129
RedHill Biopharma Inc.
$109
AstraZeneca Pharmaceuticals LP
$105
Averitas Pharma Inc.
$87
Merz Pharmaceuticals, LLC
$76
Medtronic, Inc.
$73
Lilly USA, LLC
$69
EISAI INC.
$66
Bioventus LLC
$62
Acacia Pharma Inc
$54
Kaleo, Inc.
$52
Purdue Pharma L.P.
$51
Relievant Medsystems, Inc.
$44
US WorldMeds, LLC
$43
Horizon Pharma plc
$43
ARBOR PHARMACEUTICALS, INC.
$39
Zyla Life Sciences
$36
SI-BONE, INC.
$35
Allergan Inc.
$30
BOSTON SCIENTIFIC CORPORATION
$29
Arbor Pharmaceuticals, Inc.
$29
Saluda Medical Americas, Inc.
$23
Nalu Medical, Inc.
$19
Zyla Life Sciences, Inc.
$18
UCB, Inc.
$16
AbbVie, Inc.
$16
Shionogi Inc
$16
Upsher-Smith Laboratories LLC
$15
Nuvectra Corporation
$15
Avanir Pharmaceuticals, Inc.
$14
PROTEGA PHARMACEUTIALS LLC
$14
Masimo Corporation
$13
Currax Pharmaceuticals LLC
$12
FIDIA PHARMA USA INC.
$10
Top 3 companies account for 48.6% of total payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · ALSUMA · ARYMO ER · Aimovig · Algovita · Amitiza · BARHEMSYS · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL · BUNAVAIL 2.1 mg 30-count box · Belbuca · CHANTIX · COMIRNATY · CONTRAVE · Cambia · Cimzia · DUEXIS · Dayvigo · Durolane · ELYXYB - celecoxib · EMBEDA · EMGALITY · Evoke · Evzio · GENERAL PAIN MANAGEMENT · GRALISE · Gralise · HORIZANT · Horizant · Humira · Hymovis · INTELLIS ADAPTIVESTIM · Intracept · LICART · LUCEMYRA · LYRICA · Licart · Lucemyra · MOVANTIK · Morphabond ER · Motegrity · Movantik · NAPRELAN · NURTEC ODT · Nalu Neurostimulation System · ONZETRA Xsail · OXAYDO · OXTELLAR XR · Octrode SCS Leads · Omnia · PAXLOVID · PENNSAID · PROCLAIM · Patient SafetyNet System · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · QULIPTA · QUTENZA · QUVIVIQ · RELISTOR · RELISTOR ORAL · ROXYBOND · Roxybond · SPRIX · SYMPROIC · Senza · Senza Spinal Cord Stimulation System · StimQ Receiver Stimulator Kit Channel A US w Receiver · Stimrouter Implantable Kit · Symproic · TOSYMRA SUMATRIPTAN NASAL SPRAY · TREXIMET · TROKENDI XR · Tirosint · UBRELVY · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xeomin · Xtampza ER · XtampzaER · ZIPSOR · ZOHYDRO ER · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (63%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for pain medicine in FL.
Equivalent to $320 per 100 Medicare services performed
Geographic Context
Pain medicines within 10 mi
42
Per 100K population
4.4
County median income
$70,293
Nearest hospital
WINDMOOR HEALTHCARE OF CLEARWATER
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Gerges is a clinical cardiology specialist, with above-average Medicare volume (top 12% in FL), with low-engagement industry engagement in the top 7% of FL peers, with 17 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Gerges experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gerges performed 2,914 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gerges receive payments from pharmaceutical companies?
Yes. Dr. Gerges received a total of $24,200 from 67 companies across 1,111 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gerges's costs compare to other pain medicines in Clearwater?
Dr. Gerges's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gerges) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Clearwater
Browse pain medicines in Clearwater ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in FL
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in FL
Which FL pain medicines receive the most from drug and device companies.
By company
Assertio Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from Assertio Therapeutics, Inc.
By company
Collegium Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Collegium Pharmaceutical, Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology